Iambic Therapeutics vs Insitro
Iambic Therapeutics vs Insitro, compared side by side on 21 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Iambic Therapeutics is on 61/100 and Insitro on 62/100.
Where each one leads
Iambic Therapeutics
Leads on none of the measures we hold for both companies.
Insitro
- agent readiness: 40/100 against 31/100
- domain rating: 64/100 against 48/100
- headcount: 255 against 151
- funding raised: $243M against $50.0M
- LinkedIn following: 42,173 against 17,283
At a glance
| Measure | Iambic Therapeutics | Insitro |
|---|---|---|
| What it is | AI-driven drug discovery company developing novel medicines for unmet patient needs. | Data-driven drug discovery and development company using machine learning and high-throughput biology. |
| Category | Biotech, HealthTech, Drug Discovery, AI-Driven Drug Discovery | Healthcare, Drug Discovery, Drug Development, DNA |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Software |
| Founded | 2019 | 2018 |
| Headquarters | San Diego, United States | South San Francisco, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Iambic Therapeutics | Insitro |
|---|---|---|
| Employees | 151 | 255 |
| Headcount growthLast 12 months | Not published | +10.9% |
| Total funding | $50.0M | $243M |
| Latest round | Series B Extension | Series B |
| Valuation | Not published | $7.0B |
| LinkedIn followers | 17,283 | 42,173 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Iambic Therapeutics | Insitro |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 61/100 | 62/100 |
| Traction | 60/100 | 60/100 |
| Team | 70/100 | 50/100 |
| Community | 15/100 | 8/100 |
| Search visibility | 36/100 | 62/100 |
| Quality | 68/100 | 65/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (31/100) | D (40/100) |
| Domain ratingLink authority, 0-100 | 48/100 | 64/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Iambic Therapeutics | Insitro |
|---|---|---|
| CDN | Cloudflare | Cloudflare |
| CMS | Webflow | WordPress |
| Frameworks | Not detected | Jquery |
Iambic Therapeutics vs Insitro: common questions
Which is better, Iambic Therapeutics or Insitro?
On our 0-100 score Insitro rates higher (62/100 against 61/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 21 data points above: read the rows that match what you are buying for.
How do Iambic Therapeutics and Insitro compare on the numbers?
Insitro leads on agent readiness (40/100 against 31/100), domain rating (64/100 against 48/100), headcount (255 against 151), funding raised ($243M against $50.0M), LinkedIn following (42,173 against 17,283).
Read the full Iambic Therapeutics review and pricing or the Insitro review and pricing. You can also browse other Iambic Therapeutics alternatives we track.